Release Date: 08/02/22 08:20 Summary: Update on non-binding indicative offer for BCM Price Sensitive: Yes Download Document 233.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%